Exact Sciences to Present at Wells Fargo, Baird Healthcare Events

Exact Sciences to Participate in September Investor Conferences

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

conferences

08/19/2025 - 06:00 AM

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

Wells Fargo Healthcare Conference, Boston
Fireside chat on Wednesday, September 3, 2025 at 1:30 p.m. ET
Baird Global Healthcare Conference, New York
Fireside chat on Tuesday, September 9, 2025 at 10:50 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences鈥� website at .

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company鈥檚 growing portfolio includes well-established brands such as Cologuard庐 and Oncotype DX庐, along with innovative solutions like Oncodetect鈩� for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit , follow Exact Sciences on X , or find Exact Sciences on and .